Summary of the NICE CKD guideline

This video makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". Please note that the content on this channel reflects my professional interpretation/summary of the guidance and that I am in no way affiliated with, employed by or funded/sponsored by NICE.

My name is Fernando Florido and I am a GP in the United Kingdom. In this video I go through the NICE guidelines “Chronic kidney disease: assessment and management” or NG203, Published on 25 August 2021

There is a podcast version of this and other videos that you can access here:

Primary Care guidelines podcast:

• Redcircle: https://redcircle.com/shows/primary-c...
• Spotify: https://open.spotify.com/show/5BmqS0O...
• Apple podcasts: https://podcasts.apple.com/gb/podcast...

Full NICE guideline on CKD:

• Website: https://www.nice.org.uk/guidance/ng203 or as

• Or download here: https://1drv.ms/b/s!AiVFJ_Uoigq0lgvjC...

CKD visual summaries:
• Websites:
o Identifying CKD:
https://www.nice.org.uk/guidance/ng20...
o Managing proteinuria:
https://www.nice.org.uk/guidance/ng20...
o Phosphate binders:
https://www.nice.org.uk/guidance/ng20...
• Or download here:

o Identifying CKD: https://1drv.ms/b/s!AiVFJ_Uoigq0lgxMq...

o Managing proteinuria:
https://1drv.ms/b/s!AiVFJ_Uoigq0lg2n8...

o Phosphate binders:
https://1drv.ms/b/s!AiVFJ_Uoigq0lg62G...


CKD tables- 1&2
• Download: https://1drv.ms/u/s!AiVFJ_Uoigq0lhN1H...

NICE HTA guideline:

• Full guideline:    • 2022 Hypertension Update- NICE Guidance  
• Flowchart:    • Review of NICE hypertension flowcharts  
• Shorts:
o    • # Hypertension thresholds- clinic BP  
o    • # Ambulatory & Home BP thresholds  
o    • # Hypertension treatment  


SGLT2 inhibitors for adults with CKD and type 2 diabetes, see chronic kidney disease in NICE's guideline on type 2 diabetes in adults.

• Summary of guidance: CKD section of diabetes guideline 1.8.17
For adults with type 2 diabetes and CKD who are taking an ARB or an ACE inhibitor (titrated to the highest licensed dose that they can tolerate), offer an SGLT2 inhibitor (in addition to the ARB or ACE inhibitor) if:
• ACR is over 30 mg/mmol and
• they meet the criteria in the marketing authorisation (including relevant estimated glomerular filtration rate [eGFR] thresholds).
• Website: Diabetes guideline:
https://www.nice.org.uk/guidance/ng28...

NICE's technology appraisal guidance on dapagliflozin for treating chronic kidney disease.

• Website:
https://www.nice.org.uk/guidance/ta775
• Or download here:
https://1drv.ms/b/s!AiVFJ_Uoigq0lg_O0...


NICE's technology appraisals on sodium zirconium cyclosilicate and patiromer.

• Website:
o Zirconium: https://www.nice.org.uk/guidance/ta599
o Patiromer: https://www.nice.org.uk/guidance/ta623

• Or download here:
o Zirconium:
https://1drv.ms/b/s!AiVFJ_Uoigq0lhLUk...
o Patiromer: https://1drv.ms/b/s!AiVFJ_Uoigq0lhARw...


NICE's guideline on cardiovascular disease: risk assessment and reduction, including lipid modification for the use of statins in adults with CKD.

• Website: https://www.nice.org.uk/guidance/cg181

• Or download here:
https://1drv.ms/b/s!AiVFJ_Uoigq0lhEqi...


MHRA safety advice on recombinant human erythropoietins:

• Website:
https://www.gov.uk/drug-safety-update...
• Summary of advice:
Recombinant human erythropoietins: new advice for prescribing
Over-correction of haemoglobin concentration may increase the risk of death and serious cardiovascular events in patients with chronic kidney disease; it may increase the risk of thrombosis and related complications in patients with cancer.
4-variable Kidney Failure Risk Equation
• Download:
https://1drv.ms/x/s!AiVFJ_Uoigq0lhS5k...

https://1drv.ms/x/s!AiVFJ_Uoigq0lhS5k...